CST BLOG

The official blog of Cell Signaling Technology, where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Lab Expectations listing page

Read More →

Hallmarks of Cancer: Inducing or Accessing Vasculature (Angiogenesis)

Imagine a rapidly growing city—it needs roads, plumbing, and power lines to thrive. So too, do tumor...
Susan Kane, PhD Oct 8, 2025

Anything but Rabbit: Why Multiplex with Chimeric Antibodies?

It’s a refrain you’ve likely said before: “Give me anything but rabbit!” While rabbit antibodies are...
Supriya Singh, PhD Oct 1, 2025

Astrocyte Activation Markers for CNS Injury & Neurodegenerative Disease Research

Astrocytes play an important role in the central nervous system (CNS), supplying nutrients to neuron...
Supriya Singh, PhD Sep 24, 2025

Hallmarks of Cancer: Deregulating Cellular Metabolism

Cancer cells have a high demand for biomass—cellular components such as proteins, nucleic acids, and...
Jianxin Xie, PhD Sep 17, 2025

Protect Your Drug Development Pipeline: Don't Let Antibody Supply Disrupt Your Progress

For many researchers, choosing the right antibody for a project is one of the most important parts o...
Josh Nathan Sep 10, 2025

ELISA Kit Lot-to-Lot Reproducibility: Safeguard the Quality of Your Data

Over the past eight years working as a Product Scientist at CST, a big part of my role has been to t...
Emily Estabrook Aug 27, 2025

Hallmarks of Cancer: Genome Instability and Mutation

Genetic alterations are a fundamental characteristic of cancer. When DNA mutations and chromosomal r...
Susan Keezer, PhD Aug 20, 2025

Hallmarks of Cancer: Avoiding Immune Destruction

This blog explores the mechanisms, pathways, and proteins involved in one of the Hallmarks of Cancer...
Emily Alonzo, PhD Aug 13, 2025

CST's Sustainable Supply Chain: Ambient Shipping & Antibody Stability

Did you know that around 60% of CST® antibodies are shipped at room temperature, eliminating the nee...
Alexandra Foley Aug 6, 2025

Three Reasons Flow Cytometry Controls Give You CAR Confidence

Chimeric Antigen Receptor (CAR) cell therapies continue to advance, but the high cost and lengthy ti...
Andrea Tu, PhD Jul 23, 2025

Automating PTM Profiling for Mass Spec: Scalable Proteomics Workflows Using PTMScan® Reagents

Studying post-translational modifications (PTMs) is critical for advancing our understanding of cell...
Barry Zee Jul 16, 2025

Mechanisms of Cell Death: Ferroptosis

What is ferroptosis? Ferroptosis is an iron-dependent form of programmed cell death with distinct mo...
Gary Kasof, PhD Jul 9, 2025

Top 10 Biomarkers Powering Parkinson’s Disease Research

Parkinson’s disease (PD) is a relentless, progressive neurodegenerative disease characterized by the...
Richard Cho, PhD Jun 25, 2025

Mechanisms of Cell Death: Apoptosis

What is apoptosis? Apoptosis is a form of programmed cell death (PCD) characterized by cell shrinkag...
Gary Kasof, PhD Jun 18, 2025

Mapping RNA-Protein Interactions with RBP-eCLIP: Powering Discovery in RNA Biology

Guest author Dr Vince Harjono is an Application Scientist Manager at Eclipsebio. CST and Eclipsebio ...

Key Epithelial-Mesenchymal Transition (EMT) Markers in Cancer

EMT, or epithelial-mesenchymal transition, is a biological process in which epithelial cells gain th...
Susan Keezer, PhD Jun 4, 2025

      Categories

      25-JRY-19751_TrialSize_Blog Listing Ad

      CST Newsletter

      Popular Posts

      Recent Posts
      CST blog Cellular Landscape Footer

      About Us

       

      Help & Support

      Resources

      Legal

      For Research Use Only. Not for Use in Diagnostic Procedures.
      © 2025 Cell Signaling Technology, Inc. All Rights Reserved.